With efficient blood clearance, relatively low liver uptake (0.87% ID/g at 1 h post-injection (p.i.)), and high specific uptake in PSMA-expressing tissues and tumor (tumor uptake 7.7% ID/g at 1 h p.i.), [68Ga]Ga-PSMA-11 has become the most widely used PSMA-targeting imaging agent. Here, FOLH1 is linked to neoplasm.